Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam flag Vietnam · Delayed Price · Currency is VND
57,700
+100 (0.17%)
At close: Feb 9, 2026

HOSE:DCL Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,321,5891,306,7971,143,9461,015,686703,634
Revenue Growth (YoY)
1.13%14.24%12.63%44.35%4.83%
Cost of Revenue
1,117,3451,102,093934,032733,585493,482
Gross Profit
204,244204,704209,914282,100210,152
Selling, General & Admin
145,758144,874139,188153,815123,371
Operating Expenses
145,758144,874139,188153,815123,371
Operating Income
58,48559,83070,726128,28586,781
Interest Expense
-49,129-25,494-30,530-39,627-36,264
Interest & Investment Income
-34,27939,66752,71251,929
Currency Exchange Gain (Loss)
-152.37-2,70577.03-90.68
Other Non Operating Income (Expenses)
25,3549.56953.0294.196,058
EBT Excluding Unusual Items
34,71168,77778,111141,542108,412
Gain (Loss) on Sale of Investments
----1,872
Pretax Income
34,71168,77778,111141,542110,284
Income Tax Expense
14,62014,63115,97628,62822,528
Earnings From Continuing Operations
20,09154,14562,134112,91487,756
Minority Interest in Earnings
-574.7-574.4-416.96-1,273-1,796
Net Income
19,51653,57161,717111,64185,961
Preferred Dividends & Other Adjustments
--2,0003,0002,000
Net Income to Common
19,51653,57159,717108,64183,961
Net Income Growth
-63.57%-13.20%-44.72%29.87%29.48%
Shares Outstanding (Basic)
7373737057
Shares Outstanding (Diluted)
7373737057
Shares Change (YoY)
0.07%-4.11%22.02%1.17%
EPS (Basic)
267.00733.44817.591548.461460.20
EPS (Diluted)
267.00733.00817.591548.001460.00
EPS Growth
-63.57%-10.35%-47.18%6.03%29.09%
Free Cash Flow
-40,249-103,037-200,343-683,099-123,174
Free Cash Flow Per Share
-550.64-1410.67-2742.89-9736.25-2142.18
Gross Margin
15.45%15.67%18.35%27.77%29.87%
Operating Margin
4.42%4.58%6.18%12.63%12.33%
Profit Margin
1.48%4.10%5.22%10.70%11.93%
Free Cash Flow Margin
-3.05%-7.89%-17.51%-67.25%-17.51%
EBITDA
111,90197,686109,004166,420121,054
EBITDA Margin
8.47%7.47%9.53%16.38%17.20%
D&A For EBITDA
53,41637,85638,27838,13534,273
EBIT
58,48559,83070,726128,28586,781
EBIT Margin
4.42%4.58%6.18%12.63%12.33%
Effective Tax Rate
42.12%21.27%20.45%20.23%20.43%
Revenue as Reported
1,321,5891,143,946-1,015,686703,634
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.